Today, remyelination holds real promise as a strategy for restoring lost function and slowing or even stopping MS progression. This week, we're taking a deep dive into the current state of remyelination research.
Veterans with MS are eligible to join the PVA :22
The largest MS prevalence study to date has been published. And it's yours in the RealTalk MS app! 3:26
Dr. Ruth Ann Marie on comorbidities in MS 4:29
European MS Platform Annual Conference: Understanding Progressive MS begins Thursday 5:56
MS Society of Canada 2020 MS-CONNECT Conference begins next Monday 6:56
Dr. Jeffrey Cohen talks about remyelination 9:13
Dr. Ian Duncan talks about the science behind remyelination 21:48
Share this episode 31:31
Donate to the National MS Society COVID-19 Response Fund 31:52
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/168
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
RealTalk MS Episode 168
Guests: Dr. Jeffrey Cohen, Dr. Ian Duncan
Tags: MS, MultipleSclerosis, MSResearch, MSSociety, MSActivist, EMSPVirtual2020, MSConnect, RealTalkMS